F464-0515 Screening compound: N~1~-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[9-fluoro-2-methyl-4-oxo[1]benzothieno[3,2-d]pyrimidin-3(4H)-yl]acetamide

F464-0515 Screening compound: N~1~-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[9-fluoro-2-methyl-4-oxo[1]benzothieno[3,2-d]pyrimidin-3(4H)-yl]acetamide
F464-0515 Screening compound: N~1~-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[9-fluoro-2-methyl-4-oxo[1]benzothieno[3,2-d]pyrimidin-3(4H)-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F464-0515
N~1~-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[9-fluoro-2-methyl-4-oxo[1]benzothieno[3,2-d]pyrimidin-3(4H)-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F464-0515

Molecular Formula

C21H16FN3O4S (C21 H16 FN3 O4 S)

Compound Name

N~1~-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[9-fluoro-2-methyl-4-oxo[1]benzothieno[3,2-d]pyrimidin-3(4H)-yl]acetamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-2-{13-fluoro-4-methyl-6-oxo-8-thia-35-diazatricyclo[7.4.0.0^{27}]trideca-1(13)2(7)3911-pentaen-5-yl}acetamide

SMILES

CC(N(CC(Nc(cc1)cc2c1OCCO2)=O)C1=O)=Nc2c1sc1c2c(F)ccc1

InChI

InChI=1S/C21H16FN3O4S/c1-11-23-19-18-13(22)3-2-4-16(18)30-20(19)21(27)25(11)10-17(26)24-12-5-6-14-15(9-12)29-8-7-28-14/h2-6,9H,7-8,10H2,1H3,(H,24,26)

InChI Key

HNGZQUGGIVCQQC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD11996715

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

425.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.655

Distribution Coefficient, logD

2.655

Water Solubility, LogSw

-3.14

Polar Surface Area

61.853

Acid Dissociation Constant (pKa)

11.43

Base Dissociation Constant (pKb)

1.63

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.00

F464-0515 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-Aging Library (44940 compounds)

Anticancer Library (62698 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with F464-0515 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F464-0515?
Check Price and Availability of F464-0515, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F464-0515 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F464-0515
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F464-0515
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F464-0515 available by request